✦ LIBER ✦

PCN6 A COST-EFFECTIVENESS ANALYSIS OF ADJUVANT THERAPY WITH EXEMESTANE, ANASTROZOLE, LETROZOLE OR TAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH EARLYSTAGE BREAST CANCER IN MEXICO

✍ Scribed by J Mould-Quevedo; J Tapia-Valencia; G Davila-Loaiza

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacoeconomic analysis of adjuvant th

✍ Juan Miguel Gil; Carlos Rubio-Terrés; Almudena del Castillo; Paloma González; Fe 📂 Article 📅 2006 🏛 Springer Milan 🌐 Spanish ⚖ 827 KB

Cost-utility of adjuvant hormone therapi

✍ C. Skedgel; D. Rayson; R. Dewar; T. Younis 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 694 KB

Cost utility analysis of early adjuvant

✍ Jonathan Karnon; Thomas Delea; Vicki Barghout 📂 Article 📅 2007 🏛 Springer 🌐 French ⚖ 297 KB

PCN116 A SURVIVAL BASED COST-EFFECTIVENE

✍ K El Ouagari; S Kaura; JD Karnon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

0242 Cost effectiveness analysis of letr

✍ T. Hashem; M. Al-Sherbini; N. Abd El-Bary; M. Swiha 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

PCN32 COST-EFFECTIVENESS ANALYSIS OF LET

✍ J Karnon; TE Delea; NL Papo; V Barghout; SK Thomas; SR Johnston 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB